Guido Ghilardi
-
- Chronic Lymphocytic Leukemia Research 2
-
- CAR-T cell therapy research 10
- Cancer Immunotherapy and Biomarkers 2
-
- Lymphoma Diagnosis and Treatment 3
-
- Viral Infectious Diseases and Gene Expression in Insects 2
- CRISPR and Genetic Engineering 2
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
-
- Immune Cell Function and Interaction 2
- Co-authors
- B. GerberDavide RossiGeorg StüssiMarco RuellaChristoph RöckenStephen J. SchusterLuca MazzucchelliElise A. Chong
- Cited by
- GeneticsHematologyOncology
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Guido Ghilardi
18 papers receiving 93 citations
Peers
Comparison fields: 5 of 26
- Genetics 27
- Hematology 16
- Oncology 36
- Pathology and Forensic Medicine 16
- Molecular Biology 47
Countries citing papers authored by Guido Ghilardi
This map shows the geographic impact of Guido Ghilardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Ghilardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Ghilardi more than expected).
Fields of papers citing papers by Guido Ghilardi
This network shows the impact of papers produced by Guido Ghilardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Ghilardi. The network helps show where Guido Ghilardi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guido Ghilardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 11 | |
| 14 | 2019 | 24 | |
| 15 | 2019 | 15 | |
| 16 | [Plasma-cell granuloma of the sigmoid colon concomitant with adenocarcinoma of the cecum. Viewpoint for debate, literature review on pseudotumors, idiopathic colitis and cancer]. | 1997 | 3 |
| 17 | Medical management of acromegaly: effects of SMS 201-995 in 30 patients. | 1990 | 7 |
| 18 | Gastrointestinal transit in hyperthyroid patients before and after propranolol treatment. | 1985 | 3 |
| 19 | [The behavior of the C-reactive protein in some primary and metastatic tumors]. | 1960 | 1 |
About Guido Ghilardi
Guido Ghilardi is a scholar working on Oncology, Rheumatology and Genetics, having authored 19 papers that have together received 95 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Immune Cell Function and Interaction (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), CRISPR and Genetic Engineering (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Genetics (27 citations), Hematology (16 citations) and Oncology (36 citations). Guido Ghilardi has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include B. Gerber, Davide Rossi, Georg Stüssi, Marco Ruella, Christoph Röcken, Stephen J. Schuster, Luca Mazzucchelli, Elise A. Chong, Harald Seeger and Jakub Svoboda. Their work appears in journals such as Blood, British Journal of Haematology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.